Autoimmune lymphoproliferative syndrome with somatic Fas mutations - Test2 - elhamkhani - TriplyDB

Autoimmune lymphoproliferative syndrome with somatic Fas mutations

Autoimmune lymphoproliferative syndrome with somatic Fas mutations

http://www.wikidata.org/entity/Q28285625

about

Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS)Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop How I treat autoimmune lymphoproliferative syndrome Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS)Biomarkers and Algorithms for the Diagnosis of Vitamin B12 Deficiency Approaches to Managing Autoimmune Cytopenias in Novel Immunological Disorders with Genetic Underpinnings Like Autoimmune Lymphoproliferative Syndrome Somatic mutagenesis in autoimmunity Autoimmune lymphoproliferative syndrome misdiagnosed as hemophagocytic lymphohistiocytosis Causes and consequences of the autoimmune lymphoproliferative syndrome Mutations in the 3'-untranslated region of GATA4 as molecular hotspots for congenital heart disease (CHD).Mutation analysis in primary immunodeficiency diseases: case studies.Exonic deletion of CASP10 in a patient presenting with systemic juvenile idiopathic arthritis, but not with autoimmune lymphoproliferative syndrome type IIa.Diagnosis and management of autoimmune cytopenias in childhood.Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).Elevated double negative T cells in pediatric autoimmunity ALPS-ten lessons from an international workshop on a genetic disease of apoptosis Genetics of follicular lymphoma transformation.Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.The power and the promise of restimulation-induced cell death in human immune diseases.Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation Gene defects in the soma: some get it and some don't!Clues to immune tolerance: the monogenic autoimmune syndromes Cutaneous vasculitis in patients with autoimmune polyendocrine syndrome type 1: report of a case and brief review of the literature.Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype.IL-10/Janus kinase/signal transducer and activator of transcription 3 signaling dysregulates Bim expression in autoimmune lymphoproliferative syndrome The expanding spectrum of the autoimmune lymphoproliferative syndromes NRAS mutation causes a human autoimmune lymphoproliferative syndrome.Laboratory evaluation of primary immunodeficiencies Molecular defects in T- and B-cell primary immunodeficiency diseases.Autoimmunity: basic mechanisms and implications in endocrine diseases. Part I.A rapid ex vivo clinical diagnostic assay for fas receptor-induced T lymphocyte apoptosis.Autoimmunity: twenty years in the Fas lane Deregulation of Fas ligand expression as a novel cause of autoimmune lymphoproliferative syndrome-like disease.Genetic defects of apoptosis and primary immunodeficiency.Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS)cAMP-responsive element modulator α (CREMα) trans-represses the transmembrane glycoprotein CD8 and contributes to the generation of CD3+CD4-CD8- T cells in health and disease.Autoimmune lymphoproliferative syndrome caused by a homozygous null FAS ligand (FASLG) mutation.Sequential decisions on FAS sequencing guided by biomarkers in patients with lymphoproliferation and autoimmune cytopenia.

P2860

Q24623371-DFE799C1-8332-4718-9169-5CC5A82EBF4E Q24632569-F862D4F3-D26B-4E4C-86E1-CAA588502C13 Q24633207-541E21CB-2FD0-49FE-B56F-C0959D267C5B Q24643047-C19AE876-88EB-4843-9344-1933EA6EB788 Q26742072-EC411EA0-EB1D-4AD3-B864-E4EF40FBEE1A Q26799956-5F2D66B8-194C-4352-83DD-8EE1D2254204 Q26860815-C20DCA9E-D0A7-42E4-8511-36E93BD727E3 Q28299956-CC3586C3-D3BC-435D-B66C-DE37F97BCA4D Q28300792-8E0F47C8-3D93-4400-8985-37C3C2B7482B Q33288896-0AF2381F-80A9-4DE5-9A80-FD928C05EAA2 Q33386708-4360FA8A-50DD-4142-86EA-2A7BDEA6E74B Q33394404-46653A9D-9611-463E-AA33-063BFFF6168D Q33411497-38D6A3A7-0F41-49CC-833A-E2868CD15918 Q33420245-3E8CBEB4-1D7B-46BC-B717-05619A8BF745 Q33717456-6030D190-0FBD-4184-8A47-96D73A871C1A Q33807422-7BA9A74C-7E8E-476E-BE28-DEA270A34F06 Q33910446-565314B5-FFE8-44AA-BD0B-9A09F52D8508 Q33944255-5EFE1C48-76BB-4B08-81AC-77E8EA591ED0 Q34009654-6474A22F-07FA-4332-9FC9-53DD121A969E Q34149957-E9394137-53EE-4819-8AFE-3EFC3A954676 Q34239719-9734871F-22FE-44CC-AEE9-A53F54FBA7B7 Q34428954-AD5EE363-B866-4A5E-8A52-AE6B63B5F331 Q34429062-1CBEE392-A859-4F60-9992-D9AC7C72E1BA Q34440616-1FB83147-7F36-4097-A068-8B4CEA60DE3D Q34445745-D960CE7C-912D-4140-B35A-F58F9C4B92C4 Q34513178-C0942CDB-3C8F-4003-BA0B-D31EF0FD82CD Q35130847-7A82AF2B-57E7-4CBF-AA98-E952B9D455AF Q35619447-2D2177F4-87F0-4F4C-B0C0-B27E24A33C29 Q35829141-F0996DBE-6726-4ECA-873C-242F46209850 Q36142583-18A9A40D-1C76-426B-92D0-F104452FD66B Q36302334-B2F57623-C6F3-45C6-9D21-B5E35749387C Q36522840-DA84EC4D-59E3-411D-8385-8FDA201A5073 Q36595156-DAA39BFD-055B-4876-83A7-051A0FB20701 Q36632364-58824729-5C23-4EC6-868D-7AD354872FC9 Q36708937-FB4D99E7-76BC-430D-9872-F97B468B52B6 Q37142878-F5959B12-FC17-48C1-846C-F774DF19DEED Q37219274-D85587F1-9833-49EC-9781-48F1BE558B2D Q37272180-CEFA7DB2-DB67-414D-844F-8B0C275B0A47 Q37298573-408F4A53-BF69-4F73-9DE5-BA169F1BF64B Q37377927-027D214F-8522-4BB9-90C8-BBADD789C97D

P2860

Autoimmune lymphoproliferative syndrome with somatic Fas mutations

http://www.wikidata.org/entity/Q28285625

description

2004 nî lūn-bûn

@nan

2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Autoimmune lymphoproliferative syndrome with somatic Fas mutations

@ast

Autoimmune lymphoproliferative syndrome with somatic Fas mutations

@en

Autoimmune lymphoproliferative syndrome with somatic Fas mutations

@nl

type

label

Autoimmune lymphoproliferative syndrome with somatic Fas mutations

@ast

Autoimmune lymphoproliferative syndrome with somatic Fas mutations

@en

Autoimmune lymphoproliferative syndrome with somatic Fas mutations

@nl

prefLabel

Autoimmune lymphoproliferative syndrome with somatic Fas mutations

@ast

Autoimmune lymphoproliferative syndrome with somatic Fas mutations

@en

Autoimmune lymphoproliferative syndrome with somatic Fas mutations

@nl

P1433

Q28285625-4EB532AF-E808-4A0C-B484-40D9D8834291

P1476

Q28285625-EAD4C54E-57B2-4AFF-856E-FFF69C258768

P2093

Q28285625-202ACED4-7DDD-4371-856D-7D0DAE4E3740

Q28285625-228FA84D-D59A-4273-BED6-8E4E70DD4B46

Q28285625-27ACED11-132E-4220-AD2D-78200DEC7AB4

Q28285625-7C1ECBD6-2343-4946-8E9E-9A3570C43214

Q28285625-95330BF6-FE8E-4E8E-B683-D3457996F161

Q28285625-B528A9CC-4220-4C1B-98C5-F4F7B7255E05

Q28285625-C087A56E-4C64-4CED-8135-AD0325786184

P304

Q28285625-43A17AEE-1283-4589-AEDB-4693AEEE8D62

P31

Q28285625-6496A00B-8826-4217-A9A9-0CCBA063C75A

P3181

Q28285625-93552D51-AA14-465D-8296-7CAD02D495BD

P356

Q28285625-5DA3E95E-1E38-4E6E-8A64-40EFB086FBD3

P407

Q28285625-74AA6575-E7EA-42D9-9D73-215250564800

P433

Q28285625-AACD7703-7007-43F0-AC56-616951078E44

P478

Q28285625-69E11626-E44F-48C8-A68D-4FD459EC62C0

P50

Q28285625-204FF3D3-94AA-478B-8EE8-DBA4F010D5D5

Q28285625-49F06DCB-94FC-4CEC-8F2F-12D7888BD7F3

Q28285625-5D9C1827-12C9-4C94-9285-68118398288C

Q28285625-7432244C-3163-471E-8FC7-B6B983D2C814

Q28285625-BBDDC6E9-1518-43D4-A505-A7C4455033BF

P577

Q28285625-2DDEFAA8-1C94-48B1-A768-7FDDE7E19DD8

P698

Q28285625-91E24C35-5A9A-4F77-B400-24572F79657F

P921

Q28285625-346DC17A-6ED1-4773-84ED-89D9BC161BAA

P3181

P356

P1433

The New England Journal of Medicine

P1476

Autoimmune lymphoproliferative syndrome with somatic Fas mutations

@en

P2093

Anne-Marie Prieur

http://www.w3.org/2001/XMLSchema#string

Cédric Vonarbourg

http://www.w3.org/2001/XMLSchema#string

Eliska Holzelova

http://www.w3.org/2001/XMLSchema#string

Etienne Vilmer

http://www.w3.org/2001/XMLSchema#string

Françoise Selz

http://www.w3.org/2001/XMLSchema#string

Jirina Bartunkova

http://www.w3.org/2001/XMLSchema#string

Stéphane Blanche

http://www.w3.org/2001/XMLSchema#string

P304

1409-18

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

483481

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA040036

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

351

http://www.w3.org/2001/XMLSchema#string

P50

Frédéric Rieux-Laucat

Peter D Arkwright

Françoise Le Deist

Marie-Claude Stolzenberg

P577

2004-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15459302

http://www.w3.org/2001/XMLSchema#string

P921

autoimmune lymphoproliferative syndrome